| Sacituzumab Govitecan investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 71show all (up to 200) |
|---|
| → investigated in trials for | Triple-Negative Breast Carcinomamolecular_subtype 32 trials (23 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Triple-Negative Breast Carcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Breast Neoplasmcancer_family 31 trials (26 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Breast Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Solid Neoplasm 10 trials (7 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Solid Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Non-Small Cell Carcinomasubtype 8 trials (6 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Urothelial Carcinoma 8 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Urothelial Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Invasive Breast Carcinoma 5 trials (5 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Invasive Breast Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lung Small Cell Carcinoma 5 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Lung Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Breast Neoplasmcancer_family 4 trials (4 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Breast Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Bladder Neoplasm 4 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Bladder Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glioblastomasubtype 3 trials (1 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Glioblastoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Endometrial Neoplasm 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Endometrial Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Malignant Lung Neoplasm 3 trials (3 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Malignant Lung Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ovarian Carcinoma 3 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Ovarian Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Head and Neck Squamous Cell Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | Head and Neck Squamous Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HER2-Negative Breast Carcinoma 2 trials (2 active) · conditions mapped to this cancer only (no hierarchy roll-up) | — | — | HER2-Negative Breast Carcinoma | 2 | Observed | clinicaltrials | graph → |